These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 13907933)
21. Effects of triparanol on serum low-density lipoproteins and cholesterol. ENGELBERG H Geriatrics; 1962 Aug; 17():528-31. PubMed ID: 13890232 [No Abstract] [Full Text] [Related]
22. Evaluation of a cholesterol-synthesis inhibitor (triparanol). CARVER MJ; FREEMAN JG; SMITH JA Ann Intern Med; 1960 Sep; 53():462-7. PubMed ID: 13691207 [No Abstract] [Full Text] [Related]
23. Lethal effect in dogs of prolonged triparanol oral administration. SCANU A; HAWK WA; PAGE IH Arch Pathol; 1962 Jun; 73():445-50. PubMed ID: 14497794 [No Abstract] [Full Text] [Related]
24. Studies of serum desmosterol levels in hypercholesteremic subjects treated with triparanol (MER-29). Sachs BA; Wolfman L Am J Clin Nutr; 1961; 9():760-3. PubMed ID: 14495832 [No Abstract] [Full Text] [Related]
25. Observations on the effect of triparanol (MER-29) on the serum cholesterol of selected human subjects. ROSENMAN RH; FRIEDMAN M Prog Cardiovasc Dis; 1960 May; 2():605-11. PubMed ID: 14439028 [No Abstract] [Full Text] [Related]
26. [Clinical trials in atherosclerotics with Triparanol (MER-29) diminishing the biosynthesis of cholesterol]. KELLER L; GERGELY J Z Gesamte Inn Med; 1962 Feb; 17():183-6. PubMed ID: 14454950 [No Abstract] [Full Text] [Related]
27. Effect of MER-29 (triparanol) on serum cholesterol, cholesterol esters and liver enzymes. RUSKIN A; RUSKIN B Prog Cardiovasc Dis; 1960 May; 2():624-30. PubMed ID: 14440267 [No Abstract] [Full Text] [Related]
28. Acutte effects of triparanol in man. BLANKENHORN DH; KUZMA O Metabolism; 1961 Oct; 10():763-70. PubMed ID: 13869841 [No Abstract] [Full Text] [Related]
29. Clinical experience with triparanol. BECKER MC J Med Soc N J; 1962 Feb; 59():59-64. PubMed ID: 13866353 [No Abstract] [Full Text] [Related]
30. The use of triparanol and sodium dextrothyroxine to lower serum cholesterol. GOYETTE EM; SAAD A Angiology; 1962 Feb; 13():88-93. PubMed ID: 13900898 [No Abstract] [Full Text] [Related]
31. MER-29 (triparanol) in the control of hypercholesterolaemia. JEPSON EM Proc R Soc Med; 1962 Jun; 55(6):480-4. PubMed ID: 14451692 [No Abstract] [Full Text] [Related]
33. [Experiences with Triparanol, a drug inhibiting cholesterol biosynthesis, in atherosclerotic patients]. KELLER L; GERGELY J Orv Hetil; 1962 Apr; 103():690-2. PubMed ID: 14454951 [No Abstract] [Full Text] [Related]
34. The use of triparanol in the treatment of diabetic retinopathy. GOYETTE EM; HARE J; KAZDAN P; SAAD A Ohio State Med J; 1961 Nov; 57():1252-4. PubMed ID: 13900897 [No Abstract] [Full Text] [Related]
35. A CORRELATION OF DRUG CONCENTRATION WITH STEROL BIOSYNTHESIS INHIBITION IN THE LIVER. FIGDOR SK; SCHREIBER EC; STEBBINS RB; MOORE PF; PINSON R J Med Chem; 1964 Jul; 7():508-10. PubMed ID: 14221136 [No Abstract] [Full Text] [Related]
36. [Clinical and biochemical research on the effects of triparanol (Merrel--29)]. KNUECHEL F Med Welt; 1962 Feb; 7():367-76. PubMed ID: 14457393 [No Abstract] [Full Text] [Related]
38. Effects of MER-29 on the intermediary metabolism of cholesterol. FRANTZ ID; MOBBERLEY ML; SCHROEPFER GJ Prog Cardiovasc Dis; 1960 May; 2():511-8. PubMed ID: 13824600 [No Abstract] [Full Text] [Related]
39. Effect of triparanol on adrenocortical function of man. MARKS LJ; DOIRON JC; OYAMA HT N Engl J Med; 1962 May; 266():965-7. PubMed ID: 14470055 [No Abstract] [Full Text] [Related]
40. [On some biological properties of a fluorinated analogue of Triparanol]. DELBARRE F; RICHET FG; BUU-HOI NP; JACQUIGNON P; PERIN F Med Exp Int J Exp Med; 1961; 5():437-41. PubMed ID: 13885108 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]